Provided by Tiger Trade Technology Pte. Ltd.

NewMarket

937.34
+9.731.05%
Pre-market: 935.34-2.0000-0.21%07:20 EDT
Volume:93.45K
Turnover:87.55M
Market Cap:8.62B
PE:20.17
High:946.52
Open:931.88
Low:920.83
Close:927.61
52wk High:981.66
52wk Low:580.03
Shares:9.20M
Float Shares:7.61M
Volume Ratio:0.80
T/O Rate:1.23%
Dividend:11.75
Dividend Rate:1.25%
EPS(TTM):46.47
EPS(LYR):44.44
ROE:25.12%
ROA:11.08%
PB:4.69
PE(LYR):21.09

Loading ...

NewMarket Keeps Quarterly Dividend at $3 a Share, Payable Oct. 1 to Shareholders of Record Sept. 15

MT Newswires Live
·
Aug 14

NewMarket Declares Quarterly Dividend, Signaling Ongoing Confidence

TIPRANKS
·
Aug 14

NewMarket Corporation - Declares Qtrly Dividend of $3 Per Share

THOMSON REUTERS
·
Aug 14

NewMarket Declares Quarterly Dividend of $3 Per Share

Reuters
·
Aug 14

Neuren Pharmaceuticals (ASX:NEU) Is Up 26.3% After Record DAYBUE Sales and Upgraded 2026 Royalties

Simply Wall St.
·
Aug 06

NewMarket Q2 Earnings, Net Sales Rise

MT Newswires Live
·
Jul 30

Earnings Flash (NEU) NewMarket Posts Q2 EPS of $14.54

MT Newswires Live
·
Jul 30

NewMarket Q2 FY26 Net Income Rises 20.24% to $133.8 Million; Net Sales Climb 6.96% to $747.1 Million

Reuters
·
Jul 30

NewMarket Q2 Revenue, Profit Rise on Surcharges from Higher Supply-chain Costs Amid Disruptions in the Middle East

Reuters
·
Jul 30

NewMarket Q2 EPS $14.54 Up From $11.84 YoY, Sales $747.094M Up From $698.509M YoY

Benzinga Earnings
·
Jul 30

NewMarket Q2 Sales USD 747.094 Million

THOMSON REUTERS
·
Jul 30

Earning Preview: NewMarket Q2 revenue is expected to increase by 0%, and institutional views are cautiously positive

Earnings Agent
·
Jul 22

NewMarket (NEU) Stock Looks Cheap Despite Its 182% Five Year Run

Simply Wall St.
·
Jul 19

How Investors Are Reacting To Neuren Pharmaceuticals (ASX:NEU) Larger-Than-Expected Phelan-McDermid Syndrome Population Estimate

Simply Wall St.
·
Jul 15

Newmarket Updates Financial Calendar with Upcoming Earnings Release, Conference Call and Webcast

Reuters
·
Jul 14

Growth Investors: Industry Analysts Just Upgraded Their Neuren Pharmaceuticals Limited (ASX:NEU) Revenue Forecasts By 55%

Simply Wall St.
·
Jul 07

Neuren Pharmaceuticals (ASX:NEU) Wins CHMP Backing, Is The Upside Already Priced In?

Simply Wall St.
·
Jul 02

Why Neuren Pharmaceuticals (ASX:NEU) Is Up 6.3% After Record DAYBUE Royalties And Strong STIX Launch – And What's Next

Simply Wall St.
·
May 12

Softer Q1 Results and Cash Returns Could Be A Game Changer For NewMarket (NEU)

Simply Wall St.
·
May 03

NewMarket (NEU) Margin Decline Challenges Bullish Narratives After Strong Q1 EPS

Simply Wall St.
·
Apr 24